BD1008
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BD1008 (N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-1-pyrrolidineethanamine) is a selective sigma receptor antagonist, with a reported binding affinity of K i = 2 ± 1 nM for the sigma-1 receptor and 4 times selectivity over the sigma-2 receptor. Consistent with other reported sigma receptor antagonists, pretreating Swiss Webster mice with BD1008 significantly attenuates the behavioral toxicity of cocaine, and may be potentially useful in the development of antidotes for the treatment of cocaine overdose.
BD1008 (N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-1-pyrrolidineethanamine) is a selective sigma receptor antagonist, with a reported binding affinity of K i = 2 ± 1 nM for the sigma-1 receptor and 4 times selectivity over the sigma-2 receptor. Consistent with other reported sigma receptor antagonists, pretreating Swiss Webster mice with BD1008 significantly attenuates the behavioral toxicity of cocaine, and may be potentially useful in the development of antidotes for the treatment of cocaine overdose.
See also
BD1031 LR132
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375920129 under CC BY-SA 4.0; modifications have been made.